Tumor Necrosis Factor-alpha clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Sorry, accepting new patients by invitation only
Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms
Our lead scientists for Tumor Necrosis Factor-alpha research studies include Daniel L Cooke, MD.